New US COVID-19 vaccine eyes Botswana licensing

Dubbed “the world’s COVID-19 vaccine” the new vaccine technology was developed by researchers at Texas Children’s Hospital and Baylor College of Medicine led by Drs Maria Elena Bottazzi and Peter Hotez.

The new vaccine uses traditional recombinant protein-based technology that will enable its production at large scale. At present, the most popular vaccines in the world and in Botswana use the mRNA technology and include those from Pfizer and Moderna.